Understanding the particularities of thyroid-cognition interactions in older adults is crucial in assessing the risks and evaluating therapeutic options.
Methods
Cross-sectional analyses where participants from Alzheimer’s Disease Neuroimaging Initiative (ADNI) with mild cognitive impairment (MCI) and healthy controls (HC), with complete neurocognitive tests, thyroid stimulating hormone (TSH) <10 µIU/mL, and geriatric depression scale (GDS) <5, were eligible. Linear and logistic regression models, including testing for non-linearity, were performed. Sex strata were explored.
Results
Of the total 1845 multiethnic US-participants, with a median age of 73 (IQR: 68, 78); 887 (48 %) were females, and 1056 (57 %) had MCI. The median TSH level was 1.70 µIU/mL (IQR: 1.15, 2.40); significantly lower in MCI than HC (1.66 vs. 1.74 µIU/mL, p-value=0.02). There was a significant association between TSH and overall cognition only in males (adj. ßMales=-0.40[-0.74, -0.07], p-value=0.019). The odds of being diagnosed with MCI at baseline decreased with higher TSH levels in the total study population (adj. ORTotal=0.87[0.79, 0.95], p-value=0.002) and in males (adj. ORMales=0.80[0.70, 0.92], p-value=0.001).
Conclusions
There was a sex-specific, statistically significant association between TSH levels and cognition in multiethnic middle-aged and older ADNI adults. Lower TSH levels and worse global cognition were statistically associated only in males. To precisely delineate the chronological onset of these disorders, longitudinal clinical studies are needed.
{"title":"Thyroid-stimulating hormone and cognitive impairment in non-depressed non-demented multiethnic middle-aged and older US adults: Assessing sex-specific risk prediction","authors":"Asma Hallab , Alzheimer’s Disease Neuroimaging Initiative","doi":"10.1016/j.aggp.2025.100195","DOIUrl":"10.1016/j.aggp.2025.100195","url":null,"abstract":"<div><h3>Background</h3><div>Understanding the particularities of thyroid-cognition interactions in older adults is crucial in assessing the risks and evaluating therapeutic options.</div></div><div><h3>Methods</h3><div>Cross-sectional analyses where participants from Alzheimer’s Disease Neuroimaging Initiative (ADNI) with mild cognitive impairment (MCI) and healthy controls (HC), with complete neurocognitive tests, thyroid stimulating hormone (TSH) <10 µIU/mL, and geriatric depression scale (GDS) <5, were eligible. Linear and logistic regression models, including testing for non-linearity, were performed. Sex strata were explored.</div></div><div><h3>Results</h3><div>Of the total 1845 multiethnic US-participants, with a median age of 73 (IQR: 68, 78); 887 (48 %) were females, and 1056 (57 %) had MCI. The median TSH level was 1.70 µIU/mL (IQR: 1.15, 2.40); significantly lower in MCI than HC (1.66 vs. 1.74 µIU/mL, <em>p</em>-value=0.02). There was a significant association between TSH and overall cognition only in males (adj. <em>ß</em><sub>Males</sub>=-0.40[-0.74, -0.07], <em>p</em>-value=0.019). The odds of being diagnosed with MCI at baseline decreased with higher TSH levels in the total study population (adj. OR<sub>Total</sub>=0.87[0.79, 0.95], <em>p</em>-value=0.002) and in males (adj. OR<sub>Males</sub>=0.80[0.70, 0.92], <em>p</em>-value=0.001).</div></div><div><h3>Conclusions</h3><div>There was a sex-specific, statistically significant association between TSH levels and cognition in multiethnic middle-aged and older ADNI adults. Lower TSH levels and worse global cognition were statistically associated only in males. To precisely delineate the chronological onset of these disorders, longitudinal clinical studies are needed.</div></div>","PeriodicalId":100119,"journal":{"name":"Archives of Gerontology and Geriatrics Plus","volume":"2 3","pages":"Article 100195"},"PeriodicalIF":0.0,"publicationDate":"2025-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144827715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-05DOI: 10.1016/j.aggp.2025.100194
Sanggon Nam
Background
Coronary heart disease (CHD) remains a leading cause of morbidity and mortality among older U.S. adults, with significant racial and ethnic disparities in prevalence, treatment, and outcomes. This systematic review synthesizes evidence from 44 studies published between 2000 and 2024 to examine these disparities among adults aged ≥65, focusing on prevalence, access to care, treatment quality, outcomes, contributing factors, and effective interventions.
Methods
The review adhered to PRISMA 2020 guidelines. A comprehensive search was conducted across six databases: PubMed, Embase, Scopus, Web of Science, CINAHL, and the Cochrane Library. Studies were included if they examined racial/ethnic differences in CHD among U.S. adults aged ≥65. Two independent reviewers screened titles and abstracts, followed by full-text review, with disagreements resolved by a third reviewer. Inter-rater reliability was assessed using Cohen’s kappa (0.85 for title/abstract, 0.90 for full-text). Quality assessment used the Newcastle-Ottawa Scale (NOS; high quality ≥7 points, moderate 4–6 points, low ≤3 points) for observational studies and the Cochrane Risk of Bias tool for randomized trials. Due to heterogeneity, a narrative synthesis was conducted, with subgroup analyses for key outcomes.
Results
The 44 included studies revealed persistent disparities in CHD prevalence, access, treatment, and outcomes, particularly affecting Black, Hispanic, and American Indian/Alaska Native (AI/AN) older adults. Minority groups exhibited higher CHD prevalence and risk factors (e.g., hypertension, diabetes), lower access to guideline-directed therapies, and worse outcomes, including higher readmission and mortality rates. Structural racism, socioeconomic factors, and systemic biases were key drivers. Interventions like policy reforms, community-based programs, and telehealth showed promise in reducing disparities.
Conclusions
Despite progress in acute care, significant disparities persist in long-term CHD management among minority older adults. Addressing social determinants, improving access to equitable care, and implementing culturally competent interventions are essential for health equity.
背景冠心病(CHD)仍然是美国老年人发病和死亡的主要原因,在患病率、治疗和结局方面存在明显的种族和民族差异。本系统综述综合了2000年至2024年间发表的44项研究的证据,以检查65岁以上成年人的这些差异,重点关注患病率、获得护理、治疗质量、结果、影响因素和有效干预措施。方法遵循PRISMA 2020指南。在六个数据库中进行了全面的搜索:PubMed, Embase, Scopus, Web of Science, CINAHL和Cochrane图书馆。如果研究在年龄≥65岁的美国成年人中检查了冠心病的种族/民族差异,则纳入研究。两位独立审稿人筛选标题和摘要,然后进行全文审稿,分歧由第三位审稿人解决。评估者间信度采用Cohen’s kappa(标题/摘要0.85,全文0.90)。质量评估采用纽卡斯尔-渥太华量表(NOS;高质量≥7分,中等4-6分,低质量≤3分)的观察性研究和随机试验的Cochrane偏倚风险工具。由于异质性,我们进行了叙事综合,并对关键结果进行了亚组分析。结果纳入的44项研究揭示了冠心病患病率、可及性、治疗和结局方面的持续差异,特别是对黑人、西班牙裔和美国印第安人/阿拉斯加原住民(AI/AN)老年人的影响。少数群体表现出更高的冠心病患病率和危险因素(如高血压、糖尿病),更少获得指导治疗,结果更差,包括更高的再入院率和死亡率。结构性种族主义、社会经济因素和系统性偏见是主要驱动因素。政策改革、社区项目和远程医疗等干预措施有望减少差距。结论:尽管在急症护理方面取得了进展,但少数民族老年人长期冠心病管理方面仍存在显著差异。解决社会决定因素,改善获得公平保健的机会,并实施具有文化竞争力的干预措施,对卫生公平至关重要。
{"title":"Coronary heart disease racial disparities among older adults in the U.S.: Systematic review, 2000-2024","authors":"Sanggon Nam","doi":"10.1016/j.aggp.2025.100194","DOIUrl":"10.1016/j.aggp.2025.100194","url":null,"abstract":"<div><h3>Background</h3><div>Coronary heart disease (CHD) remains a leading cause of morbidity and mortality among older U.S. adults, with significant racial and ethnic disparities in prevalence, treatment, and outcomes. This systematic review synthesizes evidence from 44 studies published between 2000 and 2024 to examine these disparities among adults aged ≥65, focusing on prevalence, access to care, treatment quality, outcomes, contributing factors, and effective interventions.</div></div><div><h3>Methods</h3><div>The review adhered to PRISMA 2020 guidelines. A comprehensive search was conducted across six databases: PubMed, Embase, Scopus, Web of Science, CINAHL, and the Cochrane Library. Studies were included if they examined racial/ethnic differences in CHD among U.S. adults aged ≥65. Two independent reviewers screened titles and abstracts, followed by full-text review, with disagreements resolved by a third reviewer. Inter-rater reliability was assessed using Cohen’s kappa (0.85 for title/abstract, 0.90 for full-text). Quality assessment used the Newcastle-Ottawa Scale (NOS; high quality ≥7 points, moderate 4–6 points, low ≤3 points) for observational studies and the Cochrane Risk of Bias tool for randomized trials. Due to heterogeneity, a narrative synthesis was conducted, with subgroup analyses for key outcomes.</div></div><div><h3>Results</h3><div>The 44 included studies revealed persistent disparities in CHD prevalence, access, treatment, and outcomes, particularly affecting Black, Hispanic, and American Indian/Alaska Native (AI/AN) older adults. Minority groups exhibited higher CHD prevalence and risk factors (e.g., hypertension, diabetes), lower access to guideline-directed therapies, and worse outcomes, including higher readmission and mortality rates. Structural racism, socioeconomic factors, and systemic biases were key drivers. Interventions like policy reforms, community-based programs, and telehealth showed promise in reducing disparities.</div></div><div><h3>Conclusions</h3><div>Despite progress in acute care, significant disparities persist in long-term CHD management among minority older adults. Addressing social determinants, improving access to equitable care, and implementing culturally competent interventions are essential for health equity.</div></div>","PeriodicalId":100119,"journal":{"name":"Archives of Gerontology and Geriatrics Plus","volume":"2 3","pages":"Article 100194"},"PeriodicalIF":0.0,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144779794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hip fractures lead to disability, loss of independence, and a decline in quality of life. Rehabilitation success depends on various factors, such as, age, pre-fracture function, level of cognitive function, nutritional status, comorbidity, and family support. Most studies exploring the question of whether cognitive-based interventions can lead to functional improvement were conducted on community-dwelling elderly individuals with acquired brain injury, dementia, and cognitive impairments. Our aim was to compare targeted cognitive intervention with conventional occupational therapy in improving rehabilitation outcomes amongst post-acute hip fracture patients.
Methods
A randomized controlled single blinded study. Eighty patients were randomly assigned to two groups: group A (intervention) received targeted cognitive intervention, based on concepts from "The multi-context approach to cognitive rehabilitation of executive dysfunction" and group B (controls) received conventional occupational therapy. T-test and chi-square tests assessed significant differences between demographic, clinical, functional variables. ANOVA with repeated measures assessed significant improvement in cognitive/functional test scores in the two groups.
Results
43 patients were assigned to the intervention group; 37 to the controls. All patients significantly improved in their cognitive tests. No significant differences were found between the groups regarding discharge scores of the cognitive test, degree of cognitive improvement, functional outcomes and patient reported outcome measures questions.
Conclusions
Targeted cognitive intervention did not lead to a better outcome in hip fracture patients. As most were cognitively impaired, further research is warranted in order to explore whether different cognitive interventions might improve their rehabilitation outcomes.
{"title":"Can targeted cognitive intervention improve rehabilitation outcome in hip fracture patients: a randomized controlled trial","authors":"Yedida Borow, Renata Efrati, Noa Doron, Michal Tzin, Yaara Ginsburg, Daniela Gesner, Avital Hershkovitz","doi":"10.1016/j.aggp.2025.100193","DOIUrl":"10.1016/j.aggp.2025.100193","url":null,"abstract":"<div><h3>Background</h3><div>Hip fractures lead to disability, loss of independence, and a decline in quality of life. Rehabilitation success depends on various factors, such as, age, pre-fracture function, level of cognitive function, nutritional status, comorbidity, and family support. Most studies exploring the question of whether cognitive-based interventions can lead to functional improvement were conducted on community-dwelling elderly individuals with acquired brain injury, dementia, and cognitive impairments. Our aim was to compare targeted cognitive intervention with conventional occupational therapy in improving rehabilitation outcomes amongst post-acute hip fracture patients.</div></div><div><h3>Methods</h3><div>A randomized controlled single blinded study. Eighty patients were randomly assigned to two groups: group A (intervention) received targeted cognitive intervention, based on concepts from \"The multi-context approach to cognitive rehabilitation of executive dysfunction\" and group B (controls) received conventional occupational therapy. T-test and chi-square tests assessed significant differences between demographic, clinical, functional variables. ANOVA with repeated measures assessed significant improvement in cognitive/functional test scores in the two groups.</div></div><div><h3>Results</h3><div>43 patients were assigned to the intervention group; 37 to the controls. All patients significantly improved in their cognitive tests. No significant differences were found between the groups regarding discharge scores of the cognitive test, degree of cognitive improvement, functional outcomes and patient reported outcome measures questions.</div></div><div><h3>Conclusions</h3><div>Targeted cognitive intervention did not lead to a better outcome in hip fracture patients. As most were cognitively impaired, further research is warranted in order to explore whether different cognitive interventions might improve their rehabilitation outcomes.</div></div>","PeriodicalId":100119,"journal":{"name":"Archives of Gerontology and Geriatrics Plus","volume":"2 3","pages":"Article 100193"},"PeriodicalIF":0.0,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144779793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-27DOI: 10.1016/j.aggp.2025.100191
Mandy Simpson, Cynthia Tuuli, Elizabeth Eate
Objective
This study aimed to draw attention and give voice to women’s experiences, knowledge, future thoughts and general understanding of perimenopause and menopause, exploring this natural event holistically through a biopsychosocial lens.
Methods
One focus group of four self-identified perimenopausal or menopausal women was conducted to gather data. Purposive sampling was used to recruit the participants through a social media campaign. Interpretative Phenomenological Analysis provided a framework to study this important topic through exploring and examining lived experiences in a small group sample size, using the framework’s seven-step data analysis to identify key themes within the data.
Results
Four main group experiential themes were highlighted through analysis of the participants' responses: (1) onset and impact of symptoms, (2) menopause and relationships, (3) the knowledge gap, and (4) future thoughts: a desire for change. A prominent overarching theme involved the participants showing less concern for how they were being personally affected by their climacteric experience but demonstrating greater concern for the impact of their perimenopause or menopause experience upon others. This overarching theme was evident within all four group experiential themes.
Conclusions
The participants were deeply concerned about how their symptoms affected others. They had limited knowledge when their own symptoms started, but after seeking support, particularly from people with lived experiences rather than academic literature, they became inspired to be a part of bringing about change for the next generation, so that in the future menopause experiences would not occur so unexpectedly for others.
{"title":"A UK study: Menopausal and perimenopausal women’s biopsychosocial experiences, understanding of treatment options, and thoughts towards their future lives","authors":"Mandy Simpson, Cynthia Tuuli, Elizabeth Eate","doi":"10.1016/j.aggp.2025.100191","DOIUrl":"10.1016/j.aggp.2025.100191","url":null,"abstract":"<div><h3>Objective</h3><div>This study aimed to draw attention and give voice to women’s experiences, knowledge, future thoughts and general understanding of perimenopause and menopause, exploring this natural event holistically through a biopsychosocial lens.</div></div><div><h3>Methods</h3><div>One focus group of four self-identified perimenopausal or menopausal women was conducted to gather data. Purposive sampling was used to recruit the participants through a social media campaign. Interpretative Phenomenological Analysis provided a framework to study this important topic through exploring and examining lived experiences in a small group sample size, using the framework’s seven-step data analysis to identify key themes within the data.</div></div><div><h3>Results</h3><div>Four main group experiential themes were highlighted through analysis of the participants' responses: (1) onset and impact of symptoms, (2) menopause and relationships, (3) the knowledge gap, and (4) future thoughts: a desire for change. A prominent overarching theme involved the participants showing less concern for how they were being personally affected by their climacteric experience but demonstrating greater concern for the impact of their perimenopause or menopause experience upon others. This overarching theme was evident within all four group experiential themes.</div></div><div><h3>Conclusions</h3><div>The participants were deeply concerned about how their symptoms affected others. They had limited knowledge when their own symptoms started, but after seeking support, particularly from people with lived experiences rather than academic literature, they became inspired to be a part of bringing about change for the next generation, so that in the future menopause experiences would not occur so unexpectedly for others.</div></div>","PeriodicalId":100119,"journal":{"name":"Archives of Gerontology and Geriatrics Plus","volume":"2 3","pages":"Article 100191"},"PeriodicalIF":0.0,"publicationDate":"2025-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144827714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-26DOI: 10.1016/j.aggp.2025.100192
Olga Naka, Panagiota Chatzidou, Katia Sarafidou, Vassiliki Anastassiadou
The aging population presents complex challenges to oral health, particularly due to inflammaging, a chronic, low-grade systemic inflammation linked to tissue degeneration and frailty syndrome. Despite its relevance, inflammaging remains underexplored in geriatric prosthodontics. This scoping review aimed to systematically examine and classify existing literature on oral-systemic inflammaging, with emphasis on diagnostic biomarkers, therapeutic strategies, and interdisciplinary integration. Bloom’s cognitive taxonomy was used to structure the evidence according to levels of complexity and clinical application. Following the PRISMA-ScR guidelines, 1686 records were screened across four databases (PubMed, Scopus, Web of Science, and Embase), and 49 studies met the inclusion criteria. The review employed a dual framework: the PICO model for clinical relevance and Bloom’s instructional taxonomy to categorize evidence from recall-level biological markers to higher-order insights, such as senotherapeutics, multi-omics diagnostics, and digital integration. Findings highlighted strong correlations between systemic inflammatory markers and oral aging conditions. Novel interventions, including senolytics, mTOR inhibitors, and microbiome-targeted therapies, showed translational promise. However, gaps persist in standardized biomarker panels, long-term clinical trials, and integration of frailty metrics into prosthodontic care. In conclusion, inflammaging offers a compelling biological perspective for transitioning prosthodontic strategies from mechanical approaches to precision-based methodologies. Integrating concepts including geroscience, salivary diagnostics, and personalized biomaterials can enhance outcomes and resilience in older adults. Future research should prioritize biologically informed protocols, interdisciplinary collaboration, and AI-supported predictive tools to align prosthodontics with the broader goals of healthy aging.
人口老龄化给口腔健康带来了复杂的挑战,特别是由于炎症,一种与组织变性和虚弱综合征相关的慢性、低度全身炎症。尽管炎症具有相关性,但在老年口腔修复学中仍未得到充分研究。本综述旨在系统地检查和分类现有的关于口腔全身炎症的文献,重点是诊断生物标志物、治疗策略和跨学科整合。布鲁姆的认知分类法被用来根据复杂程度和临床应用来构建证据。按照PRISMA-ScR指南,在四个数据库(PubMed、Scopus、Web of Science和Embase)中筛选了1686条记录,49项研究符合纳入标准。该综述采用了双重框架:临床相关性的PICO模型和Bloom的教学分类法,将证据从回忆水平的生物标记物分类到更高层次的见解,如老年治疗、多组学诊断和数字集成。研究结果强调了全身炎症标志物与口腔衰老状况之间的强烈相关性。新的干预措施,包括抗衰老药、mTOR抑制剂和微生物组靶向治疗,显示出了转化的希望。然而,在标准化的生物标志物面板、长期临床试验和将脆弱指标整合到修复护理中,差距仍然存在。总之,炎症为修复策略从机械方法过渡到基于精确的方法提供了令人信服的生物学观点。整合包括老年科学、唾液诊断和个性化生物材料在内的概念可以提高老年人的预后和恢复能力。未来的研究应优先考虑生物学知情协议、跨学科合作和人工智能支持的预测工具,以使修复学与健康老龄化的更广泛目标保持一致。
{"title":"Translating inflammaging: The bidirectional relationship between oral and systemic health in geriatric prosthodontics","authors":"Olga Naka, Panagiota Chatzidou, Katia Sarafidou, Vassiliki Anastassiadou","doi":"10.1016/j.aggp.2025.100192","DOIUrl":"10.1016/j.aggp.2025.100192","url":null,"abstract":"<div><div>The aging population presents complex challenges to oral health, particularly due to inflammaging, a chronic, low-grade systemic inflammation linked to tissue degeneration and frailty syndrome. Despite its relevance, inflammaging remains underexplored in geriatric prosthodontics. This scoping review aimed to systematically examine and classify existing literature on oral-systemic inflammaging, with emphasis on diagnostic biomarkers, therapeutic strategies, and interdisciplinary integration. Bloom’s cognitive taxonomy was used to structure the evidence according to levels of complexity and clinical application. Following the PRISMA-ScR guidelines, 1686 records were screened across four databases (PubMed, Scopus, Web of Science, and Embase), and 49 studies met the inclusion criteria. The review employed a dual framework: the PICO model for clinical relevance and Bloom’s instructional taxonomy to categorize evidence from recall-level biological markers to higher-order insights, such as senotherapeutics, multi-omics diagnostics, and digital integration. Findings highlighted strong correlations between systemic inflammatory markers and oral aging conditions. Novel interventions, including senolytics, mTOR inhibitors, and microbiome-targeted therapies, showed translational promise. However, gaps persist in standardized biomarker panels, long-term clinical trials, and integration of frailty metrics into prosthodontic care. In conclusion, inflammaging offers a compelling biological perspective for transitioning prosthodontic strategies from mechanical approaches to precision-based methodologies. Integrating concepts including geroscience, salivary diagnostics, and personalized biomaterials can enhance outcomes and resilience in older adults. Future research should prioritize biologically informed protocols, interdisciplinary collaboration, and AI-supported predictive tools to align prosthodontics with the broader goals of healthy aging.</div></div>","PeriodicalId":100119,"journal":{"name":"Archives of Gerontology and Geriatrics Plus","volume":"2 3","pages":"Article 100192"},"PeriodicalIF":0.0,"publicationDate":"2025-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144749567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-25DOI: 10.1016/j.aggp.2025.100189
Yuho Shimizu
Previous studies have developed interventions aimed at simultaneously promoting long-term life planning and reducing ageism among younger individuals. Building on this work, the present study developed a novel intervention based on Protection Motivation Theory and evaluated its effectiveness in a sample of younger participants (N = 498). The intervention comprised the following components: a free-writing task addressing potential negative future events (to target threat appraisal), an explanatory text aimed at reducing ageism, a free-writing task designed to enhance hope for the future, and an explanatory text intended to strengthen the perception that life planning is both meaningful and achievable (to target coping appraisal). Following the intervention, participants demonstrated increased emphasis on life planning, stronger behavioral intentions regarding life planning, and greater hope for the future. Additionally, levels of ageism and aging anxiety significantly decreased. Given its effectiveness in enhancing a wide range of psychological and attitudinal outcomes, this intervention shows strong potential for implementation in educational settings targeting younger populations.
{"title":"Development and evaluation of a Protection Motivation Theory-based intervention to promote life planning and reduce ageism among younger people","authors":"Yuho Shimizu","doi":"10.1016/j.aggp.2025.100189","DOIUrl":"10.1016/j.aggp.2025.100189","url":null,"abstract":"<div><div>Previous studies have developed interventions aimed at simultaneously promoting long-term life planning and reducing ageism among younger individuals. Building on this work, the present study developed a novel intervention based on Protection Motivation Theory and evaluated its effectiveness in a sample of younger participants (<em>N</em> = 498). The intervention comprised the following components: a free-writing task addressing potential negative future events (to target threat appraisal), an explanatory text aimed at reducing ageism, a free-writing task designed to enhance hope for the future, and an explanatory text intended to strengthen the perception that life planning is both meaningful and achievable (to target coping appraisal). Following the intervention, participants demonstrated increased emphasis on life planning, stronger behavioral intentions regarding life planning, and greater hope for the future. Additionally, levels of ageism and aging anxiety significantly decreased. Given its effectiveness in enhancing a wide range of psychological and attitudinal outcomes, this intervention shows strong potential for implementation in educational settings targeting younger populations.</div></div>","PeriodicalId":100119,"journal":{"name":"Archives of Gerontology and Geriatrics Plus","volume":"2 3","pages":"Article 100189"},"PeriodicalIF":0.0,"publicationDate":"2025-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144757449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
This study investigated the relationship of moderate-to-vigorous-intensity non-exercise physical activity (NEPA) and exercise habits (EH) with sarcopenia in community-dwelling older adults.
Methods
A 7-year longitudinal analysis was conducted using data of 863 older adults from the Kashiwa Cohort Study in Japan, with baseline assessment in 2014 and follow-up in 2016, 2018, and 2021. Sarcopenia was assessed using the Asian Working Group for Sarcopenia 2019 criteria. NEPA status and EH were evaluated using the Global Physical Activity Questionnaire and a self-reported questionnaire according to the Japanese National Health and Nutrition Survey, respectively.
Results
Cox regression analysis identified baseline NEPA and EH as predictors of cumulative sarcopenia incidence. The incidence of new-onset sarcopenia and adjusted hazard ratios (95 % confidence interval [CI]) were 10.7 % and 0.49 (0.25–0.94) for NEPA only, 9.6 % and 0.44 (0.23–0.85) for EH only, and 8.0 % and 0.40 (0.22–0.72) for both, respectively, compared with 18.9 % for the neither NEPA nor EH group. Generalized estimating equations (GEE) analysis revealed that the odds of sarcopenia were significantly lower in the NEPA only, EH only, and both NEPA and EH groups, with adjusted odds ratios (95 % CI) of 0.52 (0.28–0.96), 0.48 (0.24–0.95), and 0.36 (0.20–0.63), respectively.
Conclusions
Both NEPA and EH were independently associated with a lower sarcopenia incidence. Therefore, NEPA may be a practical alternative to structured exercises for older adults.
{"title":"Association of non-exercise physical activity with sarcopenia compared with that of exercise habits among community-dwelling older adults: A 7-year follow-up from the Kashiwa Cohort Study","authors":"Weida Lyu , Tomoki Tanaka , Bo-Kyung Son , Yasuyo Yoshizawa , Katsuya Iijima","doi":"10.1016/j.aggp.2025.100188","DOIUrl":"10.1016/j.aggp.2025.100188","url":null,"abstract":"<div><h3>Aim</h3><div>This study investigated the relationship of moderate-to-vigorous-intensity non-exercise physical activity (NEPA) and exercise habits (EH) with sarcopenia in community-dwelling older adults.</div></div><div><h3>Methods</h3><div>A 7-year longitudinal analysis was conducted using data of 863 older adults from the Kashiwa Cohort Study in Japan, with baseline assessment in 2014 and follow-up in 2016, 2018, and 2021. Sarcopenia was assessed using the Asian Working Group for Sarcopenia 2019 criteria. NEPA status and EH were evaluated using the Global Physical Activity Questionnaire and a self-reported questionnaire according to the Japanese National Health and Nutrition Survey, respectively.</div></div><div><h3>Results</h3><div>Cox regression analysis identified baseline NEPA and EH as predictors of cumulative sarcopenia incidence. The incidence of new-onset sarcopenia and adjusted hazard ratios (95 % confidence interval [CI]) were 10.7 % and 0.49 (0.25–0.94) for NEPA only, 9.6 % and 0.44 (0.23–0.85) for EH only, and 8.0 % and 0.40 (0.22–0.72) for both, respectively, compared with 18.9 % for the neither NEPA nor EH group. Generalized estimating equations (GEE) analysis revealed that the odds of sarcopenia were significantly lower in the NEPA only, EH only, and both NEPA and EH groups, with adjusted odds ratios (95 % CI) of 0.52 (0.28–0.96), 0.48 (0.24–0.95), and 0.36 (0.20–0.63), respectively.</div></div><div><h3>Conclusions</h3><div>Both NEPA and EH were independently associated with a lower sarcopenia incidence. Therefore, NEPA may be a practical alternative to structured exercises for older adults.</div></div>","PeriodicalId":100119,"journal":{"name":"Archives of Gerontology and Geriatrics Plus","volume":"2 3","pages":"Article 100188"},"PeriodicalIF":0.0,"publicationDate":"2025-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144749568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-12DOI: 10.1016/j.aggp.2025.100187
Megha Goel , Esme Fuller-Thomson
Purpose
Depression among older adults is associated with greater negative physical health, social, and economic outcomes than in younger populations. The objective of this study was to examine factors associated with lifetime depression in a nationally representative sample of Canadian older adults, highlighting characteristics linked to both vulnerability and resilience.
Methods
Secondary analysis of the 2022 Mental Health Access to Care Survey (MHACS) was conducted to estimate the prevalence and factors associated with lifetime depression among adults aged 55 and older (n = 3,535). The MHACS measured depression using the World Health Organization’s Composite International Diagnostic Interview (WHO-CIDI). Multivariable logistic regression of lifetime depression was conducted analyzing demographic and socioeconomic variables, adverse childhood experiences, physical health measures, health behaviors, and protective psychosocial factors.
Results
One in eleven older adults (9.2%) had experienced depression at some point in their lives. Middle-aged adults (55–64 years) compared to older respondents, and females compared to males had twice the odds of lifetime depression. Other factors associated with depression included childhood physical or sexual abuse, higher educational attainment, history of substance use disorders, multiple chronic physical health conditions, lower sense of life meaning, and higher spirituality.
Conclusion
Lifetime depression in older adults is associated with a complex interplay of risk and protective factors. Identifying these factors can support early recognition and targeted intervention, potentially improving outcomes and quality of life in this population.
{"title":"Examining early adversities, demographic, health and psychosocial factors associated with lifetime depression among older Canadians: Findings from a nationally representative study","authors":"Megha Goel , Esme Fuller-Thomson","doi":"10.1016/j.aggp.2025.100187","DOIUrl":"10.1016/j.aggp.2025.100187","url":null,"abstract":"<div><h3>Purpose</h3><div>Depression among older adults is associated with greater negative physical health, social, and economic outcomes than in younger populations. The objective of this study was to examine factors associated with lifetime depression in a nationally representative sample of Canadian older adults, highlighting characteristics linked to both vulnerability and resilience.</div></div><div><h3>Methods</h3><div>Secondary analysis of the 2022 Mental Health Access to Care Survey (MHACS) was conducted to estimate the prevalence and factors associated with lifetime depression among adults aged 55 and older (<em>n</em> = 3,535). The MHACS measured depression using the World Health Organization’s Composite International Diagnostic Interview (WHO-CIDI). Multivariable logistic regression of lifetime depression was conducted analyzing demographic and socioeconomic variables, adverse childhood experiences, physical health measures, health behaviors, and protective psychosocial factors.</div></div><div><h3>Results</h3><div>One in eleven older adults (9.2%) had experienced depression at some point in their lives. Middle-aged adults (55–64 years) compared to older respondents, and females compared to males had twice the odds of lifetime depression. Other factors associated with depression included childhood physical or sexual abuse, higher educational attainment, history of substance use disorders, multiple chronic physical health conditions, lower sense of life meaning, and higher spirituality.</div></div><div><h3>Conclusion</h3><div>Lifetime depression in older adults is associated with a complex interplay of risk and protective factors. Identifying these factors can support early recognition and targeted intervention, potentially improving outcomes and quality of life in this population.</div></div>","PeriodicalId":100119,"journal":{"name":"Archives of Gerontology and Geriatrics Plus","volume":"2 3","pages":"Article 100187"},"PeriodicalIF":0.0,"publicationDate":"2025-07-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144687421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-04DOI: 10.1016/j.aggp.2025.100184
Philip Cole Brewer , Timi Kehinde Ojo , Killian Joseph Bucci , Connor John O-Brien , Dami Taiwo Ojo , Emmanuel I. Nathaniel , Nathan Gerhard Faulstich , Adebobola Imeh-Nathaniel , Richard Goodwin , Thomas I Nathaniel
Background
The objective of this study is to identify risk factors that contribute to sex differences in Alzheimer dementia (AD) patients that also present with irritability and anger (ADIA) and determine whether these factors are different between male and female patients with ADIA.
Method
We used data from the of database for AD with a history of irritability and collected from a large academic center from 2016 to 2020. A total of 128,769 patients with AD were identified: 72,896 females and 55,873 males. Univariate was used to stratified risk factors base on sex and presence or absence of anger and irritability among AD patients. The adjusted odds ratios (ORs) and 95 % confidence intervals (CIs) for each risk factor or demographic were used to predict the odds of a specific risk factors being associated with male or female ADIA.
Result
In the adjusted analysis, male ADIA patients were more likely to present with hypertension (OR = 2.894, 95 % CI, 2.079–4.028), insomnia (OR = 1.736, 95 % CI, 1.132–2.663), dyslipidemia (OR = 1.974, 95 % CI, 1.119–3.482), and peripheral vascular disease (OR = 44.135, 95 % CI, 4.344–448.364). Females were more likely to present with osteoporosis (OR = 0.002, 95 % CI, 0.001–0.023), gait dysfunction (OR = 0.034, 95 % CI, 0.003–0.452), anxiety (OR = 0.634, 95 % CI, 0.472–0.852), urinary tract infection (OR = 0.157, 95 % CI, 0.063–0.393), headaches (OR = 0.121, 95 % CI, 0.052–0.282) and pneumonia (OR = 0.209, 95 % CI, 0.114–0.384).
Conclusion
This study reveals key sex differences in ADIA patients. A population-based approach that tackles inequalities in risk factors may offer population-based healthcare and care of male and female ADIA patients.
{"title":"Sex differences in risk factors associated with Alzheimer’s dementia patients with irritability and anger","authors":"Philip Cole Brewer , Timi Kehinde Ojo , Killian Joseph Bucci , Connor John O-Brien , Dami Taiwo Ojo , Emmanuel I. Nathaniel , Nathan Gerhard Faulstich , Adebobola Imeh-Nathaniel , Richard Goodwin , Thomas I Nathaniel","doi":"10.1016/j.aggp.2025.100184","DOIUrl":"10.1016/j.aggp.2025.100184","url":null,"abstract":"<div><h3>Background</h3><div>The objective of this study is to identify risk factors that contribute to sex differences in Alzheimer dementia (AD) patients that also present with irritability and anger (ADIA) and determine whether these factors are different between male and female patients with ADIA.</div></div><div><h3>Method</h3><div>We used data from the of database for AD with a history of irritability and collected from a large academic center from 2016 to 2020. A total of 128,769 patients with AD were identified: 72,896 females and 55,873 males. Univariate was used to stratified risk factors base on sex and presence or absence of anger and irritability among AD patients. The adjusted odds ratios (ORs) and 95 % confidence intervals (CIs) for each risk factor or demographic were used to predict the odds of a specific risk factors being associated with male or female ADIA.</div></div><div><h3>Result</h3><div>In the adjusted analysis, male ADIA patients were more likely to present with hypertension (OR = 2.894, 95 % CI, 2.079–4.028), insomnia (OR = 1.736, 95 % CI, 1.132–2.663), dyslipidemia (OR = 1.974, 95 % CI, 1.119–3.482), and peripheral vascular disease (OR = 44.135, 95 % CI, 4.344–448.364). Females were more likely to present with osteoporosis (OR = 0.002, 95 % CI, 0.001–0.023), gait dysfunction (OR = 0.034, 95 % CI, 0.003–0.452), anxiety (OR = 0.634, 95 % CI, 0.472–0.852), urinary tract infection (OR = 0.157, 95 % CI, 0.063–0.393), headaches (OR = 0.121, 95 % CI, 0.052–0.282) and pneumonia (OR = 0.209, 95 % CI, 0.114–0.384).</div></div><div><h3>Conclusion</h3><div>This study reveals key sex differences in ADIA patients. A population-based approach that tackles inequalities in risk factors may offer population-based healthcare and care of male and female ADIA patients.</div></div>","PeriodicalId":100119,"journal":{"name":"Archives of Gerontology and Geriatrics Plus","volume":"2 3","pages":"Article 100184"},"PeriodicalIF":0.0,"publicationDate":"2025-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144579383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}